7.3 C
Glasgow
Wednesday, March 4, 2026
spot_img

More News

Next-generation flu vaccine development financed by EU

Jim Cornall -
SK bioscience, IDT Biologika (IDT) and Vaxxas have been selected for phase 1 of a next-generation vaccine development initiative...

Panome Bio looks to new metabolomics data solution for biomarker discovery and drug development

Jim Cornall -
Panome Bio, a multi-omics contract research organisation, has launched MassID, a cloud-based computational platform designed to improve how researchers...

Valinor and Renew partner to generate largest neurological disease multi-omics dataset

Jim Cornall -
Valinor Discovery and Renew Biotechnologies are set to collaborate to generate the largest clinical multi-omics dataset to date for...

New lab to speed up diagnostic innovation for biotech and pharma partners

Jim Cornall -
ARUP Laboratories, the largest nonprofit reference laboratory in the US, has launched an Innovation Central Laboratory to facilitate collaboration...

Gallbladder cancer could soon be detected in blood

Jim Cornall -
Researchers at Tezpur University in Assam, India, working with scientists at the University of Illinois Urbana-Champaign, have identified distinct...

Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases

Jim Cornall -
The conversations on this week’s podcast are with CEO of Merz Therapeutics, Stefan König, about a variety of neurodegenerative...

Pfizer metastatic colorectal cancer treatment gets FDA approval

Jim Cornall -
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI (encorafenib)...

Every Cure to receive up to $76m to advance AI-identified drug repurposing opportunities

Jim Cornall -
Every Cure, a nonprofit with a mission to save and improve lives by repurposing existing medicines, has been selected...

Key protein in Alzheimer’s disease protection

Jim Cornall -
Alzheimer’s disease affects approximately 50m people worldwide and is a devastating disease with limited treatment options currently available. "Alzheimer's is...

Machine-learning biomarker identifies those at high risk for liver cancer

Jim Cornall -
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a...

New AI approach enables diagnosis and monitoring of brain tumours

Jim Cornall -
An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis...

Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

Jim Cornall -
Nuclera and leadXpro are set to collaborate by bringing together eProtein Discovery's rapid multiplex membrane protein screening with leadXpro's...

Korsana Biosciences emerges from stealth with $175m to tackle neurodegenerative diseases

Jim Cornall -
Korsana Biosciences, Inc., a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, has...

New centre for cell research

Jim Cornall -
A new centre for cell research is being set up at the University of Konstanz in Germany. The Single Cell...

PLL Therapeutics reports results from ALS trial

Jim Cornall -
PLL Therapeutics, a biopharmaceutical company developing a groundbreaking polypeptide delivery platform to treat the root cause of autoimmune and...

Aggressive oral cancer can be identified at an early stage by changes in lymphatic vessels

Jim Cornall -
Oral cancers are the most common malignant tumours in the head and neck region, causing more than 188,000 deaths...

Stopping malignant stem cells from becoming cancer cells

Jim Cornall -
In a new study in Nature Communications, a research team at the University of Oslo in Norway have examined...

Bacteria with built-in compass could be used as microbots for drug delivery

Jim Cornall -
Some bacterial species can use the Earth’s magnetic field to orient themselves. To better understand this, a team led by...

Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy

Jim Cornall -
The conversations on this week’s podcast focus on a rapid and accurate prostate cancer diagnostic test, with Valley Diagnostics’...

Modifying CAR T-cells to kill solid tumours

Jim Cornall -
A team led by LMU physician Sebastian Kobold has found a way to allow the body’s immune system to...

New company created to tackle paediatric cerebral palsy

Jim Cornall -
Kidswell Bio Corporation and Treehill Partners are creating a new US-based regenerative medicine company, Kidswell USA. It is being formed...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media